Einhorn Pitches 5 Turnaround Stocks, Sees Centene Worth Up to $102 on AI Gains
Updated
Updated · CNBC · May 12
Einhorn Pitches 5 Turnaround Stocks, Sees Centene Worth Up to $102 on AI Gains
1 articles · Updated · CNBC · May 12
Five turnaround names topped David Einhorn’s Sohn Conference pitch, with Greenlight arguing overlooked companies can rerate as management fixes operations and adopts AI.
Centene was his clearest AI call: Einhorn said automating claims processing could restore margins after 2025 medical-cost pressure, implying a value of $85 to $102 a share versus about $56 now.
Acadia Healthcare and Fluor were framed as operational rebound plays, with Acadia needing 70%-80% occupancy at newer facilities and better insurer reimbursement, while Fluor rides U.S. spending on data centers, LNG, nuclear and manufacturing.
Versant Media and Victoria’s Secret rounded out the list, with Einhorn citing Versant’s free cash flow at more than 60% of market value over four years and Victoria’s Secret offering roughly 74% upside despite tariff-hit margins.
The broader thesis was that investors still anchor on past problems, leaving room for multiple expansion if these companies convert strategic changes into steadier growth and higher profitability.
Why is David Einhorn selling shares of Victoria's Secret while publicly predicting its stock will soar by 74%?
Can AI truly rescue health insurers' margins when its implementation costs are massive and immediate returns are unproven?